Patents by Inventor Herbert Andres

Herbert Andres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130243758
    Abstract: The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: March 13, 2013
    Publication date: September 19, 2013
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Herbert ANDRES, Sanne Lysbet DE HAAS, Johann KARL, Stefan SCHERER, Norbert WILD
  • Patent number: 8449551
    Abstract: A device (10,10?,20,20?) for digitizing a center of rotation of a hip joint implant component (A,F) with respect to a bone element in computer-assisted surgery. The device (10,10?,20,20?) comprises a detectable member (12,22) trackable for position and orientation by a computer-assisted surgery system (30). A body (11,21) is connected to the detectable member (12,22) in a known geometry. The body (11,21) has a coupling portion (14,14?,24,25) adapted to be coupled to the hip joint implant component (A,F) in a predetermined configuration. The center of rotation of the hip joint implant component (A,F) is calculable in the predetermined configuration as a function of the known geometry and of the position and orientation of the detectable member (12,22).
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: May 28, 2013
    Assignee: Orthosoft Inc.
    Inventors: Louis-Philippe Amiot, Herbert André Jansen, Isabelle Fontaine, Daniel Odermatt
  • Patent number: 8426167
    Abstract: The present invention relates to the cloning and expression of foreign protein or polypeptides in bacteria, such as Escherichia coli. In particular, this invention relates to expression tools comprising a FKBP-type peptidyl prolyl isomerase selected from the group consisting of FkpA, SlyD, and trigger factor; methods of recombinant protein expression, the recombinant polypeptides thus obtained, as well as to the use of such polypeptides.
    Type: Grant
    Filed: April 13, 2007
    Date of Patent: April 23, 2013
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Christian Scholz, Herbert Andres, Elke Faatz, Alfred Engel, Urban Schmitt, Ariuna Bazarsuren, Peter Schaarschmidt
  • Publication number: 20130073067
    Abstract: A computer-assisted surgery system for guiding alterations to a bone, comprises a trackable member secured to the bone. The trackable member has a first inertial sensor unit producing orientation-based data. A positioning block is secured to the bone, and is adjustable once the positioning block is secured to the bone to be used to guide tools in altering the bone. The positioning block has a second inertial sensor unit producing orientation-based data. A processing system providing an orientation reference associating the bone to the trackable member comprises a signal interpreter for determining an orientation of the trackable member and of the positioning block. A parameter calculator calculates alteration parameters related to an actual orientation of the positioning block with respect to the bone.
    Type: Application
    Filed: August 17, 2012
    Publication date: March 21, 2013
    Inventors: Louis-Philippe Amiot, Yannick Boutin, Yonik Breton, Karine Duval, Herbert Andre Jansen, Benoît Pelletier, Catherine Proulx, Alain Richard, Myriam Valin, Joel Zuhars
  • Patent number: 8265790
    Abstract: A computer-assisted surgery system for planning/guiding alterations to a bone in surgery, comprises a trackable member adapted to be secured to the bone. The trackable member has a first inertial sensor unit producing orientation-based data for at least two degrees of freedom in orientation of the trackable member A positioning block is adapted to be secured to the bone, with at least an orientation of the positioning block being adjustable once the positioning block is secured to the bone to reach a selected orientation at which the positioning block is used to guide tools in altering the bone. The positioning block has a second inertial sensor unit producing orientation-based data for at least two degrees of freedom in orientation of the positioning block. A processing system providing an orientation reference associating the bone to the trackable member comprises a signal interpreter for determining an orientation of the trackable member and of the positioning block from the orientation-based data.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: September 11, 2012
    Assignee: Orthosoft, Inc.
    Inventors: Louis-Philippe Amiot, Yannick Boutin, Yonik Breton, Karine Duval, Herbert Andre Jansen, Benoît Pelletier, Catherine Proulx, Alain Richard, Myriam Valin, Joel Zuhars
  • Publication number: 20120196303
    Abstract: The present invention relates to the assessment of lung cancer. It discloses the use of protein CYBP in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring CYBP in said sample. Measurement of CYBP can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
    Type: Application
    Filed: October 11, 2011
    Publication date: August 2, 2012
    Inventors: Herbert Andres, Johann Karl, Julia Riedlinger, Markus Roessler, Michael Tacke, Michael Thierolf
  • Publication number: 20110251835
    Abstract: A device (10,10?,20,20?) for digitizing a center of rotation of a hip joint implant component (A,F) with respect to a bone element in computer-assisted surgery. The device (10,10?,20,20?) comprises a detectable member (12,22) trackable for position and orientation by a computer-assisted surgery system (30). A body (11,21) is connected to the detectable member (12,22) in a known geometry. The body (11,21) has a coupling portion (14,14?,24,25) adapted to be coupled to the hip joint implant component (A,F) in a predetermined configuration. The center of rotation of the hip joint implant component (A,F) is calculable in the predetermined configuration as a function of the known geometry and of the position and orientation of the detectable member (12,22).
    Type: Application
    Filed: June 22, 2011
    Publication date: October 13, 2011
    Inventors: Louis-Philippe Amiot, Herbert André Jansen, Isabelle Fontaine, Daniel Odermatt
  • Publication number: 20110171676
    Abstract: The present invention relates to the assessment of lung cancer. It discloses the use of protein ASC in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring ASC in the sample. Measurement of ASC can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
    Type: Application
    Filed: December 15, 2010
    Publication date: July 14, 2011
    Inventors: Herbert Andres, Marie-Luise Hagmann, Johann Karl, Markus Roessler, Michael Tacke
  • Patent number: 7897404
    Abstract: The invention relates to a process for the production of a biomolecule-linker conjugate of uniform stochiometry. It especially relates to a conjugate consisting of a biomolecule of a molecular weight between 5 kD and 500 kD and a hydrophilic linker molecule said linker having a molecular weight between 1 and 15 kD and between 4 and 60 charged residues, characterized in that said conjugate comprises at least one biomolecule-linker product of uniform stoichiometry in a pre-selected amount.
    Type: Grant
    Filed: August 26, 2001
    Date of Patent: March 1, 2011
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Eva Hoess, Herbert Andres, Frederic Donie, Rudolf Vogel, Hans-Peter Josel, Rupert Hermann, Herbert Von Der Eltz
  • Patent number: 7877131
    Abstract: A computer-assisted surgery system for guiding an operator in altering a pelvis. A sensing apparatus is provided for tracking a reference tool and a bone altering tool. A position calculator calculates a position and orientation of a pelvic frame of reference as a function of the tracking of the reference tool, and for calculating a position and orientation of the bone altering tool with respect to the frame of reference. A source of posture data and a posture data correction calculator are provided and are operative to provide a display of information allowing an operator to take into consideration the posture data from the source of posture data when altering the pelvis. A display unit is connected to the position calculator and to the posture data correction calculator for displaying the display of information and the bone altering tool with respect to the pelvic frame of reference.
    Type: Grant
    Filed: October 6, 2003
    Date of Patent: January 25, 2011
    Assignee: Orthosoft Inc.
    Inventors: Herbert André Jansen, Isabelle Fontaine, Daniel Odermatt
  • Patent number: 7846653
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein ASC (apoptosis-associated speck-like protein containing a caspase-associated recruitment domain) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring ASC in said sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Grant
    Filed: June 20, 2007
    Date of Patent: December 7, 2010
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Herbert Andres, Marie-Luise Hagmann, Johann Karl, Ursula Kunert, Gabriele Pestlin
  • Publication number: 20100240068
    Abstract: The present invention relates to a method for assessing colorectal cancer (CRC) in vitro including measuring in a sample the concentration and/or activity of a seprase polypeptide and/or fragments thereof and of either anti-p53 and/or osteopontin and/or ferritin, of optionally one or more other marker of CRC, and using the combined measurement result in the assessment of CRC. Furthermore, it especially relates to a method for assessing CRC from a liquid sample, derived from an individual by measuring seprase and at least anti-p53, ferritin and/or osteopontin in the sample. The method according to the present invention can, e.g., be used in the early detection of cancer by screening of asymptomatic individuals or in the surveillance of patients who undergo surgery.
    Type: Application
    Filed: June 2, 2010
    Publication date: September 23, 2010
    Inventors: Johann Karl, Herbert Andres, Ursula Garczarek, Wolfgang Rollinger, Norbert Wild
  • Publication number: 20100159479
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein TIMP-1 (tissue inhibitor of metalloproteinase 1) as a marker molecule in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual, the method involving measuring TIMP-1 in the sample. Measurement of TIMP-1 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: November 6, 2009
    Publication date: June 24, 2010
    Inventors: Wolfgang Rollinger, Johann Karl, Norbert Wild, Herbert Andres, Peter Heiss, Ursula Garczarek, Andrea Geistanger, Friedemann Krause
  • Patent number: 7731938
    Abstract: The present invention relates to the assessment of colorectal cancer. It discloses the use of the CYFRA 21-1 assay in the assessment of colorectal cancer. It also relates to a method for assessing colorectal cancer in vitro using a liquid sample, derived from an individual by measuring CYFRA 21-1 in said sample. Measurement of CYFRA 21-1 can, e.g., be used in the early detection or in the follow-up of patients with colorectal cancer.
    Type: Grant
    Filed: June 19, 2007
    Date of Patent: June 8, 2010
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Johann Karl, Herbert Andres, Veit Peter Grunert, Wolfgang Rollinger, Werner Zolg
  • Patent number: 7668584
    Abstract: An interface apparatus (20) for tracking by a tracking system (40) of an object(s) in space for position and orientation and for interacting with the tracking system (40). The interface apparatus (30) comprises passive detectable devices (12,14,16,22) trackable for position by the tracking system (40). A mounting device (10,24) receives the passive detectable devices (12,14,16,22) in a known geometry, and is secured to the object(s) such that a position and orientation of the object(s) is calculable by the tracking system (40) as a function of a tracking of the known geometry of the passive detectable devices (12,14,16,22). One of the passive detectable devices (22) is displaceable with respect to the object(s). A displacement of the passive detectable device (22) with respect to the object(s) is detectable to initiate an interaction with the tracking system (40) while maintaining the tracking of the object(s).
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: February 23, 2010
    Assignee: Orthosoft Inc.
    Inventor: Herbert André Jansen
  • Publication number: 20090286328
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein S100A12 in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual by measuring S100A12 in said sample. Measurement of S100A12 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: November 4, 2008
    Publication date: November 19, 2009
    Inventors: Norbert Wild, Herbert Andres, Ursula Garczarek, Andrea Geistanger, Marie-Luise Hagmann, Johan Karl, Freidemann Krause, Michael Pfeffer, Wolfgang Rollinger, Michael Tacke, Michael Thiefolf
  • Publication number: 20090264618
    Abstract: Disclosed herein are branched linkers of the formula: Zn-Y-Xm Wherein X, Y, Z, m, and n are as defined herein. The branched linkers are useful for producing conjugates that are used in diagnostic or therapeutic methods. Methods of producing the branched linkers are also described.
    Type: Application
    Filed: February 13, 2009
    Publication date: October 22, 2009
    Inventors: Herbert Andres, Hans-Peter Josel, Eva Hoess, Rupert Herrmann, Herbert Von Der Eltz
  • Publication number: 20090248044
    Abstract: A computer-assisted surgery system for planning/guiding alterations to a bone in surgery, comprises a trackable member adapted to be secured to the bone. The trackable member has a first inertial sensor unit producing orientation-based data for at least two degrees of freedom in orientation of the trackable member A positioning block is adapted to be secured to the bone, with at least an orientation of the positioning block being adjustable once the positioning block is secured to the bone to reach a selected orientation at which the positioning block is used to guide tools in altering the bone. The positioning block has a second inertial sensor unit producing orientation-based data for at least two degrees of freedom in orientation of the positioning block. A processing system providing an orientation reference associating the bone to the trackable member comprises a signal interpreter for determining an orientation of the trackable member and of the positioning block from the orientation-based data.
    Type: Application
    Filed: March 25, 2009
    Publication date: October 1, 2009
    Inventors: Louis-Philippe Amiot, Yannick Boutin, Yonik Breton, Karine Duval, Herbert Andre Jansen, Benoit Pelletier, Catherine Proulx, Alain Richard, Myriam Valin, Joel Zuhars
  • Patent number: 7579158
    Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein cellular retinoic acid binding protein II in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring cellular retinoic acid binding protein II in said sample. Measurement of cellular retinoic acid binding protein II can, e.g., be used in the early detection or diagnosis of breast cancer.
    Type: Grant
    Filed: December 5, 2005
    Date of Patent: August 25, 2009
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Gabriele Pestlin, Herbert Andres, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Werner Zolg
  • Patent number: 7566542
    Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein ASC in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring ASC in the sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of breast cancer.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: July 28, 2009
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Gabriele Pestlin, Herbert Andres, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Werner Zolg